Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TRIB stock hub

Trinity Biotech plc has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TRIBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TRIB

In the news

Latest news · TRIB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROEn/a

P25 -106.6P50 -46.9P75 -3.1

ROIC-15.6

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TRIB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

195

Groups with data

Currency

USD

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000888721
Company name	Trinity Biotech plc
Country	Ireland
Country code	US
Cusip	896438306
Employees	401
Employees Change	21%
Employees Change Percent	5.53
Enterprise value	$144.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US8964385046
Last refreshed	2026-05-10
Market cap	$11.4M
Market cap category	Nano-Cap
Price	$0.61
Price currency	USD
Rev Per Employee	109,189.53x
Sector	Healthcare
Sic	2835
Symbol	TRIB
Website	https://www.trinitybiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-328.97%
EV/Sales	3.29x
FCF yield	-52.96%
P/S ratio	0.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-21.8%
EBITDA Margin	-15.67%
Gross margin	38.57%
Gross Profit	$16.9M
Gross Profit Growth	-21.24%
Gross Profit Growth3 Y	-0.74%
Gross Profit Growth5 Y	-19.05%
Net Income	$-37.4M
Net Income Growth Years	0%
Pretax Margin	-84.91%
Profit Margin	-85.36%
Profit Per Employee	$-93,207
ROA	-5.72
Roa5y	-6.83
ROCE	26.48
ROIC	-15.65
Roic5y	-17.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-36.32%
Cagr15y	-24.89%
Cagr1y	-21.42%
Cagr20y	-18.86%
Cagr3y	-50.89%
Cagr5y	-47.32%
EPS Growth Years	0
Revenue Growth	-28.87x
Revenue Growth Years	0x
Revenue Growth3 Y	-11.2x
Revenue Growth5 Y	-15.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.42
Assets	$105.2M
Cash	$5.1M
Current Assets	$35.9M
Current Liabilities	$141.2M
Debt	$138M
Equity	$-72M
Interest Coverage	-0.45
Liabilities	$177.1M
Long Term Assets	$69.3M
Long Term Liabilities	$35.9M
Net Cash	$-132.8M
Net Cash By Market Cap	$-1,169
Tangible Book Value	$-129M
Tangible Book Value Per Share	$-6.73
WACC	12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.25
Inventory Turnover	1.41
Net Working Capital	$368,000
Quick ratio	0.12
Working Capital	$-105.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.73%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$1.1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-98.9%
1Y total return	-21.41%
200-day SMA	0.9
3Y total return	-88.16%
50-day SMA	0.66
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.94%
All Time High	151.9
All Time High Change	-99.6%
All Time High Date	2000-03-10
All Time Low	0.48
All Time Low Change	26.44%
All Time Low Date	2025-04-07
ATR	0.05
Beta	0.87
Beta1y	3.28
Beta2y	2.24
Ch YTD	-23.27
High	0.64
High52	3.44
High52 Date	2025-08-14
High52ch	-82.36%
Low	0.59
Low52	0.5
Low52 Date	2026-03-31
Low52ch	21.09%
Ma50ch	-8.05%
Price vs 200-day SMA	-32.87%
RSI	42.56
RSI Monthly	37.99
RSI Weekly	40.94
Sharpe ratio	0.36x
Sortino ratio	0.88
Total Return	-19.73%
Tr YTD	-23.27
Tr15y	-98.63%
Tr1m	0.25%
Tr1w	-0.1%
Tr3m	-24.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-9.5M
Operating margin	-21.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,688,843%
Float Percent	78.46%
Net Borrowing	11,813,000
Shares Insiders	3.02%
Shares Institutions	4.09%
Shares Out	18,720,332
Shares Qo Q	2.71%
Shares Yo Y	19.73%
Short Ratio	2.19
Short Shares	3.82

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-6.3M
Average Volume	70,129.15x
Bv Per Share	-3.76
CAPEX	$-88,000
Ch10y	-98.9
Ch15y	-98.71
Ch1m	0.25
Ch1w	-0.1
Ch1y	-21.41
Ch20y	-98.55
Ch3m	-24.14
Ch3y	-88.16
Ch5y	-95.94
Ch6m	-35.78
Change	2.52%
Change From Open	-3.51
Close	0.59
Days Gap	6.25
Depreciation Amortization	2,684,000
Dollar Volume	45,471.4
Earnings Date	2026-06-30
Earnings Time	bmo
EBIT	$-9.5M
EBITDA	$-6.9M
EPS	$-2
F Score	3
FCF	$-6M
FCF EV Yield	-4.17x
FCF Per Share	$-0.32
Financing CF	12,052,000
Fiscal Year End	December
Founded	1,992
Income Tax	$199,000
Investing CF	-6,223,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2025-12-23
Last Report Date	2025-12-31
Last Split Date	2024-02-23
Last Split Type	Reverse
Last10k Filing Date	2026-04-30
Ma150	0.82
Ma150ch	-26.12%
Ma20	0.65
Ma20ch	-7.29%
Net CF	-29,000
Next Earnings Date	2026-05-22
Open	0.63
Optionable	Yes
Position In Range	29.5
Post Close	0.61
Postmarket Change Percent	-0.05
Postmarket Price	$0.61
Ppne	5,302,000
Price Date	2026-05-08
Relative Volume	1.07x
Revenue	43,785,000x
SBC By Revenue	0.74x
Share Based Comp	324,000
Tax By Revenue	0.45x
Tr20y	-98.47%
Tr6m	-35.78%
Volume	74,924

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TRIB pay a dividend?

Capital-return profile for this ticker.

Performance

TRIB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TRIB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.1%

Float: +78.5% of shares outstanding

Insider ownership

+3.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TRIB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.6

Neutral momentum band

Price vs 200-day MA

-32.9%

50/200-day relationship not available

Beta (5Y)

0.87

Moves roughly with the market

Sharpe ratio

0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TRIB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TRIB stock rating?

Trinity Biotech plc is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TRIB analysis?

The full report lives at /stocks/TRIB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TRIB?

The latest report frames TRIB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TRIB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.